Kucukal, E., Man, Y., Hill, A., Liu, S., Bode, A., Bakhshiani, M., Kadambi, J., Little, J., & Gurkan, U.(2020).Whole blood viscosity and red blood cell adhesion: Potential biomarkers for targeted and curative therapies in sickle cell disease.American Journal of Hematology,95(11),1246-1256.
Man, Y., Kucukal, E., Bakhshiani, M., Bode, A., Little, J., & Gurkan, U.(2020).Standardized microfluidic assessment of red blood cell mediated microcapillary occlusion: association with clinical phenotype and hydroxyurea responsiveness in sickle cell disease.Microcirculation.
Kucukal, E., Man, Y., Quinn, E., Tewari, N., Bakhshiani, M., Ilich, A., Key, N., Little, J., & Gurkan, U.(2020).Red blood cell adhesion to ICAM-1 is mediated by fibrinogen and is associated with right-to-left shunts in sickle cell disease.Blood Advances,4(15),3688-3698.
Noomuna, P., Risinger, M., Zhou, S., Seu, K., Man, Y., Bakhshiani, M., Sheik, D., Wan, J., Little, J., Gurkan, U., Turrini, F., Kalfa, T., & Low, P.(2020).Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.British Journal of Haematology,190(4),599-609.
Man, Y., Goreke, U., Kucukal, E., Hill, A., Bakhshiani, M., Liu, S., Bode, A., Solis-Fuentes, A., Nayak, L., Little, J., & Gurkan, U.(2020).Leukocyte adhesion to P-selectin and the inhibitory role of Crizanlizumab in sickle cell disease: A standardized microfluidic assessment.Blood Cells, Molecules, and Diseases,83
Man, Y., Kucukal, E., Bakhshiani, M., Watson, Q., Bosch, J., Zimmerman, P., Little, J., & Gurkan, U.(2020).Microfluidic assessment of red blood cell mediated microvascular occlusion.Lab on a Chip,20(12),2086-2099.
